CF
Poolbeg Pharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| POLB 001 | Prevention of Cancer Immunotherapy-Induced Cytokine Release Syndrome (CRS) | Phase 1b/2 |
| Oral Encapsulated GLP-1 | Obesity | Preclinical |
| AI Programme - Influenza | Influenza | Discovery |
| AI Programme - RSV | Respiratory Syncytial Virus (RSV) | Discovery |